Ad

Home / Business / Sanofi sees strong earnings despite COVID vaccine delay

Sanofi sees strong earnings despite COVID vaccine delay

-
French pharmaceutical group Sanofi posts strong 2021 sales and expects another good performance in 2022
Sanofi sees strong earnings despite COVID vaccine delay Sanofi sees strong earnings despite COVID vaccine delay Reviewed by A R Margaish on 2/04/2022 Rating: 5

Ad

Powered by Blogger.